Updates are available Correction dated 2020-10-06
Click to view Correction: https://doi.org/10.1007/s12020-020-02479-y
-
Authors
Efstathiadou, Zoe A. https://orcid.org/0000-0002-7345-7912
Kostoulas, Charilaos
Polyzos, Stergios A.
Adamidou, Fotini
Georgiou, Ioannis
Kita, Marina
- License Information
-
More Information
Article History
Received: 22 May 2020
Accepted: 28 July 2020
First Online: 9 August 2020
Change Date: 6 October 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: Written informed consent has been obtained by the patients.
: Zoledronic acid had been administered in these patients off-label, at the setting of good clinical practice, since no approved treatment currently exists for HCS. Subsequently, written patients’ informed consent to publish data and photographs were obtained, and ethics committee (IRB of Hippokration Hospital of Thessaloniki) approved publication before data access.
